Table 1.
Baseline characteristics of study participants
| tAMD | PCV | P | |
|---|---|---|---|
| Number of patients | 31 | 20 | |
| Age (mean ± SD) | 70.3 ± 7.2 | 69.5 ± 7.5 | 0.686* |
| Sex (male/female) | 24/7 | 16/4 | 0.826† |
| Angiographic classification (classic/occult)‡ | 24/7 | 6/14 | 7.81 × 10−4† |
| GLD (μm, mean ± SD) | 3172 ± 1352 | 3550 ± 1321 | 0.834* |
| Mean BCVA, logMAR vision (mean ± SD) | 0.85 ± 0.33 | 0.73 ± 0.40 | 0.141* |
| Mean BCVA, corresponding approximate decimal visual acuity | 0.141 | 0.186 | |
| Mean CRT (μm, mean ± SD) | 489 ± 143 | 541 ± 195 | 0.815* |
Notes:
*
Unpaired t-test;
†
Chi-square test;
‡
fluorescein angiographic classification, classic indicates patients with lesions composed of predominantly or minimally classic CNV and occult indicates patients with lesions composed of occult with no classic choroidal neovascularization (CNV).
Abbreviations: tAMD, typical neovascular age-related macular degeneration; PCV, polypoidal choroidal vasculopathy; SD, standard deviation; GLD, greatest linear dimension; BCVA, best corrected visual acuity; logMAR, logarithm of minimum angular resolution; CRT, central retinal thickness.